BASEL, Switzerland & MYSTIC, Conn.--(BUSINESS WIRE)--Syngenta Crop Protection has reached a new milestone in its collaboration with AI-informed crop health company Enko® to discover novel weed control molecules, advancing efforts to bring much-needed innovation in herbicide technology to farmers. The collaboration targets a new Mode of Action (MoA), which is the way the herbicide controls susceptible plants. The discovery of new leads targeting this MoA was made using Enko’s ENKOMPASS™ platform, which reduces time and cost compared to conventional agricultural R&D approaches.

Today, resistant, aggressive weeds, such as Palmer amaranth, waterhemp, and many types of grasses such as blackgrass and Italian ryegrass, are a major challenge to the health of crops worldwide. Total crop losses to weeds worldwide are estimated at US $32 billion a year. Using new MoAs and different methods of controlling the weeds – such as manual weeding or crop rotations – are crucial to addressing the challenge of resistant weeds and ensuring the sustainability of crop protection solutions.

The collaboration is focused on a new, plant-specific MoA which is part of Syngenta’s “Safer by Design” research strategy that aims to deliver higher yields while lowering the impact to the planet through more sustainable technologies. The goal is the discovery of novel weed control molecules capable of controlling a broad spectrum of weeds that affect vital cropping systems worldwide.

Camilla Corsi, Head of Research at Syngenta Crop Protection: “As an innovation leader, Syngenta is pursuing some of the most cutting-edge research in the field of agricultural technology. This novel solution will be an important breakthrough in the field of weed control and will represent a critical tool for resistance management.”

Jacqueline Heard, CEO and Co-founder, Enko: “Weed and pest adaptation to changing climate conditions and resistance to on-market products will create a dearth of food in many parts of the world as populations grow. By using our ENKOMPASS platform, we can significantly reduce discovery time for new safe crop protection solutions and get them into the hands of farmers as quickly as possible."

The discovery milestone represents the advancement of new molecules, discovered as part of a multi-year collaboration between Enko and Syngenta, to the proof-of-concept phase. The weed control collaboration builds on the success of fungal control research that was announced earlier this year and adds new herbicide capabilities to the alliance.

Syngenta Media Relations
Michelle Ng
michelle.ng@syngentagroup.com

Enko Media Relations
Karin Whiting-Burgess
Karin.Whiting-Burgess@enko.ag

About Syngenta
Syngenta is a global leader in agricultural innovation with a presence in more than 100 countries. Syngenta is focused on developing technologies and farming practices that empower farmers, so they can make the transformation required to feed the world’s population while preserving our planet. Its bold scientific discoveries deliver better benefits for farmers and society on a bigger scale than ever before. Guided by its Sustainability Priorities, Syngenta is developing new technologies and solutions that support farmers to grow healthier plants in healthier soil with a higher yield. Syngenta Crop Protection is headquartered in Basel, Switzerland; Syngenta Seeds is headquartered in the United States. Read our stories and follow us on LinkedIn, Instagram & X.

About Enko®
Enko (Enko Chem Inc.) designs safe and sustainable solutions to farmers’ biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs. Founded in 2017, and led by a team of proven scientists, entrepreneurs, and agriculture industry veterans, Enko is backed by investors including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Nufarm, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund. Enko is headquartered in Mystic, Connecticut, USA. For more information, visit www.enko.ag. Follow us on LinkedIn, Instagram, and X.

Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR (“legitimate interest”). However, if you do not wish to receive further information about Syngenta, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement.

Cautionary Statement Regarding Forward-Looking Statements
This document may contain forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

©2024 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland.

Enko’s Cautionary Statement Regarding Forward-Looking Statements
This press release contains forecasts, projections, goals, plans, and other forward-looking statements. Such forward-looking statements are based on Enko's assumptions, estimates, outlook, and other judgments made in light of information available at the time of preparation of such statements and involve both known and unknown risks and uncertainties. Accordingly, plans, goals, and other statements may not be realized as described, and actual financial results, success/failure or progress of development, and other projections may differ materially from those presented herein. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Enko’s control and that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Enko does not intend to update any forward-looking statements appearing herein in the event of changing circumstances or otherwise, and such statements are current only as of the date they are made.

©Enko. 62 Maritime Drive, Mystic, CT 06355 USA

‍

Link to release on wire.

‍

‍